Soluble B7-H1: Differences in production between dendritic cells and T cells

Immunology Letters

Volumn 142, Issue 1-2, 2012, Pages 78-82

  Frigola, Xavier ^a   Inman, Brant A ^b   Krco, Christopher J ^a   Liu, Xin ^a   Harrington, Susan M ^a   Bulur, Peggy A ^a   Dietz, Allan B ^a   Dong, Haidong ^a   Kwon, Eugene D ^a  

^a MAYO CLINIC   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

B7 H1; Coregulatory; Dendritic cell; Soluble; T cell; Tumor cell

Indexed keywords

PROGRAMMED DEATH 1 LIGAND 1;

APOPTOSIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNOBIOLOGY; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; LETTER; LYMPHOCYTE ACTIVATION; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN SYNTHESIS; T LYMPHOCYTE;

ANTIGENS, CD274; APOPTOSIS; CARCINOMA, RENAL CELL; DENDRITIC CELLS; HOMEOSTASIS; HUMANS; KIDNEY NEOPLASMS; LYMPHOCYTE ACTIVATION; SOLUBILITY; T-LYMPHOCYTES;

EID: 84857194083     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2011.11.001     Document Type: Letter

References (18)

1. Flies D.B., Chen L. The new B7s: playing a pivotal role in tumor immunity. J Immunother 2007, 30:251-260.
2. Inman B.A., Frigola X., Dong H., Kwon E.D. Costimulation, coinhibition and cancer. Curr Cancer Drug Targets 2007, 7:15-30.
3. Dong H., Zhu G., Tamada K., Chen L. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat Med 1999, 5:1365-1369.
4. Chapoval A.I., Ni J., Lau J.S., Wilcox R.A., Flies D.B., Liu D., et al. B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production. Nat Immunol 2001, 2:269-274.
5. Sica G.L., Choi I.H., Zhu G., Tamada K., Wang S.D., Tamura H., et al. B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. Immunity 2003, 18:849-861.
6. Zang X., Loke P., Kim J., Murphy K., Waitz R., Allison J.P. B7x: a widely expressed B7 family member that inhibits T cell activation. Proc Natl Acad Sci USA 2003, 100:10388-10392.
7. Azuma T., Yao S., Zhu G., Flies A.S., Flies S.J., Chen L. B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells. Blood 2008, 111:3635-3643.
8. Krambeck A.E., Thompson R.H., Dong H., Lohse C.M., Park E.S., Kuntz S.M., et al. B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival. Proc Natl Acad Sci USA 2006, 103:10391-10396.
9. Roth T.J., Sheinin Y., Lohse C.M., Kuntz S.M., Frigola X., Inman B.A., et al. B7-H3 ligand expression by prostate cancer: a novel marker of prognosis and potential target for therapy. Cancer Res 2007, 67:7893-7900.
10. Thompson R.H., Gillett M.D., Cheville J.C., Lohse C.M., Dong H., Webster W.S., et al. Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target. Proc Natl Acad Sci USA 2004, 101:17174-17179.
11. Her M., Kim D., Oh M., Jeong H., Choi I. Increased expression of soluble inducible costimulator ligand (ICOSL) in patients with systemic lupus erythematosus. Lupus 2009, 18:501-507.
12. Wan B., Nie H., Liu A., Feng G., He D., Xu R., et al. Aberrant regulation of synovial T cell activation by soluble costimulatory molecules in rheumatoid arthritis. J Immunol 2006, 177:8844-8850.
13. Frigola X., Inman B.A., Lohse C.M., Krco C.J., Cheville J.C., Thompson R.H., et al. Identification of a soluble form of B7-H1 that retains immunosuppressive activity and is associated with aggressive renal cell carcinoma. Clin Cancer Res 2011, 17:1915-1923.
14. Simon I., Liu Y., Krall K.L., Urban N., Wolfert R.L., Kim N.W., et al. Evaluation of the novel serum markers B7-H4, Spondin 2, and DcR3 for diagnosis and early detection of ovarian cancer. Gynecol Oncol 2007, 106:112-118.
15. Simon I., Zhuo S., Corral L., Diamandis E.P., Sarno M.J., Wolfert R.L., et al. B7-h4 is a novel membrane-bound protein and a candidate serum and tissue biomarker for ovarian cancer. Cancer Res 2006, 66:1570-1575.
16. Thompson R.H., Zang X., Lohse C.M., Leibovich B.C., Slovin S.F., Reuter V.E., et al. Serum-soluble B7x is elevated in renal cell carcinoma patients and is associated with advanced stage. Cancer Res 2008, 68:6054-6058.
17. Zhang G., Hou J., Shi J., Yu G., Lu B., Zhang X. Soluble CD276 (B7-H3) is released from monocytes, dendritic cells and activated T cells and is detectable in normal human serum. Immunology 2008, 123:538-546.
18. Inman B.A., Frigola X., Harris K.J., Kuntz S.M., Lohse C.M., Leibovich B.C., et al. Questionable relevance of {gamma}{delta} T lymphocytes in renal cell carcinoma. J Immunol 2008, 180:3578-3584.